CLINICAL_TRIALS
trial_result
· 2020-06-18
Clinical Trial Update: Immunotherapy of Stage III/IV Melanoma Patients [Phase 1]
Summary
Phase 1 immunotherapy trial in stage III/IV melanoma completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2020-06-18